- Home
- INLX vs OSTX Comparison
INLX vs OSTX Comparison
Compare INLX & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLX
- OSTX
- Stock Information
- Founded
- INLX 1996
- OSTX 2018
- Country
- INLX United States
- OSTX United States
- Employees
- INLX N/A
- OSTX N/A
- Industry
- INLX EDP Services
- OSTX
- Sector
- INLX Technology
- OSTX
- Exchange
- INLX Nasdaq
- OSTX NYSE
- Market Cap
- INLX 53.5M
- OSTX 43.0M
- IPO Year
- INLX N/A
- OSTX 2024
- Fundamental
- Price
- INLX $13.65
- OSTX $1.68
- Analyst Decision
- INLX
- OSTX Strong Buy
- Analyst Count
- INLX 0
- OSTX 3
- Target Price
- INLX N/A
- OSTX $18.00
- AVG Volume (30 Days)
- INLX 12.7K
- OSTX 714.7K
- Earning Date
- INLX 08-12-2025
- OSTX 08-14-2025
- Dividend Yield
- INLX N/A
- OSTX N/A
- EPS Growth
- INLX N/A
- OSTX N/A
- EPS
- INLX N/A
- OSTX N/A
- Revenue
- INLX $17,758,634.00
- OSTX N/A
- Revenue This Year
- INLX $7.58
- OSTX N/A
- Revenue Next Year
- INLX N/A
- OSTX N/A
- P/E Ratio
- INLX N/A
- OSTX N/A
- Revenue Growth
- INLX 3.21
- OSTX N/A
- 52 Week Low
- INLX $6.95
- OSTX $1.12
- 52 Week High
- INLX $16.50
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- INLX 52.38
- OSTX N/A
- Support Level
- INLX $11.93
- OSTX N/A
- Resistance Level
- INLX $13.10
- OSTX N/A
- Average True Range (ATR)
- INLX 0.52
- OSTX 0.00
- MACD
- INLX 0.13
- OSTX 0.00
- Stochastic Oscillator
- INLX 75.20
- OSTX 0.00
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.